Nephrotic Syndrome Type 8 C3808953
A rare genetic type of nephrotic syndrome that impairs kidney function, leading to protein loss and fluid retention. Management involves medication and dietary approaches.
Key facts at a glance
- ICD-10
- Q63.9
- ICD-11
- LA00.0
- Body system
- renal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Hypertensive crisis (severe hypertension)
Changes in urination or swelling
(renal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Massive proteinuria
(renal)Ankle and foot swelling (edema)
(renal)Hyperlipidemia (elevated LDL cholesterol)
(renal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Corticosteroid therapy
Corticosteroids such as prednisone are typically the first-line treatment for nephrotic syndrome to reduce proteinuria and control inflammation in the kidneys. Response to steroids varies; most patients show improvement within 2-4 weeks of initiating therapy.
Renal disease management
Active treatment with regular monitoring by a healthcare provider is recommended.
Sodium-restricted diet
A low-sodium diet helps manage fluid retention and reduces edema in nephrotic syndrome patients. Sodium restriction typically limits intake to 1,500-2,000 mg daily.
Additional treatment options
Diuretic therapy
Loop diuretics are commonly prescribed to manage edema associated with nephrotic syndrome by promoting fluid excretion. This helps reduce swelling and discomfort while maintaining adequate kidney function.
medicationACE inhibitors or ARBs
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers help reduce proteinuria and slow kidney disease progression by decreasing intraglomerular pressure. These are often used as adjunctive therapy.
medicationKidney function surveillance
Regular monitoring of kidney function through blood tests, urine protein quantification, and blood pressure checks helps assess disease progression and treatment response.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Nephrotic Syndrome Type 8 C3808953?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Nephrotic Syndrome Type 8 C3808953. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy